Head to head for first-timers
CoreAge Rx vs vyrarx
CoreAge Rx and vyrarx both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #1 for first-timers · Grade A
Mama-Match
Best for: Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Visit CoreAge Rxvyrarx
Rank #296 for first-timers · Grade C
Mama-Match
Best for: Someone comfortable starting a conversation without knowing what the maintenance dose will cost, who will get the ceiling in writing before entering a card.
Visit vyrarxThe verdict for a first step
CoreAge Rx edges out vyrarx on the Mama-Match Score, 94 to 38 (A vs C). Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
vyrarx is still a genuine option — from $179/mo semaglutide, $329/mo tirzepatide — and "from" is doing the work: no dose ladder, no maintenance rate and no state list appear anywhere on the site. It does name its operating entity, vyrarx, Inc., in its own Terms, which several sellers here never do. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | vyrarx |
|---|---|---|
| Mama-Match Score | 94/100 · A | 38/100 · C |
| Overall rank | #1 | #296 |
| Semaglutide | $99/mo | $179/mo |
| Tirzepatide | $149/mo | $329/mo |
| Coverage | All 50 states | Not stated on the site |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Mama-Match
CoreAge Rx
Rank #1 · Grade A
What we like
- One flat monthly price, with no teaser rate that jumps after the first month — you know the number before you commit
- A clinician reads your history and will genuinely talk timing with you if you're postpartum, breastfeeding, or trying to conceive
- Semaglutide and tirzepatide in one account, so you and a clinician can choose — and switch — without starting over
The caveats
- Not the rock-bottom teaser price — a couple of marketplaces dangle a lower first-month number
- Compounded medication only, not FDA-approved brand-name Ozempic or Wegovy
- A general metabolic program, not a dedicated OB-GYN or hormone consult
Mama-Match
vyrarx
Rank #296 · Grade C
What we like
- Both starting figures are on the homepage rather than hidden behind an intake
- Names its operating entity, vyrarx, Inc., in its own Terms
- Clean FDA warning-letter screen against the full live index
The caveats
- Both prices are prefixed "From" — a floor, not a rate, with no ceiling published
- No dose ladder or maintenance price anywhere, so the cost once you titrate is unknown
- No state list published
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and vyrarx with the other providers we review for women.
Or browse the full comparison hub.